Profile data is unavailable for this security.
About the company
Biomerica, Inc. is a biomedical technology company. The Company develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians’ offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. It is also engaged in the research, development, commercialization and in certain cases regulatory approval, of patented, diagnostic-guided therapy (DGT) products to treat gastrointestinal diseases, such as irritable bowel syndrome (IBS), and other inflammatory diseases. The Company's InFoods IBS product uses a simple blood sample and is designed to identify patient-specific foods that, when removed from the diet, may alleviate IBS symptoms such as pain, bloating, diarrhea and constipation. The Company’s two subsidiaries, Biomerica de Mexico, which is used for assembly/manufacturing and BioEurope GmbH, which acts as a distributor of Biomerica products in certain markets.
- Revenue in USD (TTM)5.41m
- Net income in USD-6.35m
- Incorporated1971
- Employees62.00
- LocationBiomerica Inc17571 VON KARMAN AVENUEIRVINE 92614United StatesUSA
- Phone+1 (949) 379-2875
- Fax+1 (949) 553-1231
- Websitehttps://biomerica.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sonendo Inc | 43.87m | -60.92m | 6.41m | 216.00 | -- | 0.2147 | -- | 0.1462 | -0.6485 | -0.6485 | 0.4667 | 0.4472 | 0.4072 | 2.38 | 8.06 | 203,078.70 | -56.55 | -- | -74.56 | -- | 28.05 | -- | -138.88 | -- | 1.53 | -17.04 | 0.568 | -- | 5.30 | -- | -6.78 | -- | -- | -- |
| Vivos Therapeutics Inc | 13.80m | -13.58m | 7.07m | 114.00 | -- | 11.56 | -- | 0.5126 | -11.08 | -11.08 | 11.49 | 0.2241 | 1.13 | -- | 41.88 | 121,061.40 | -111.11 | -89.72 | -262.52 | -149.70 | 59.93 | 70.20 | -98.42 | -113.15 | -- | -- | 0.00 | -- | -13.87 | 29.48 | 43.04 | -- | -8.48 | -- |
| Fuse Medical Inc | 18.40m | 3.63m | 7.30m | 31.00 | 2.74 | -- | 1.98 | 0.3965 | 0.036 | 0.036 | 0.2307 | -0.0031 | 0.9593 | 0.7018 | 5.75 | 593,671.90 | 18.91 | 0.7504 | 48.45 | 1.35 | 64.95 | 54.98 | 19.72 | 0.6552 | 0.3143 | -1.13 | 1.12 | -- | -8.67 | -6.72 | 295.11 | 34.66 | -- | -- |
| Vapotherm Inc | 68.67m | -58.19m | 7.74m | 182.00 | -- | -- | -- | 0.1128 | -9.88 | -9.88 | 11.38 | -8.97 | 0.7902 | 1.44 | 6.95 | 377,302.20 | -66.96 | -49.73 | -86.11 | -62.54 | 41.27 | 43.56 | -84.74 | -78.99 | 1.23 | -1.98 | 2.07 | -- | 2.80 | 10.14 | 48.62 | -- | -10.38 | -- |
| Sigyn Therapeutics Inc | 0.00 | -4.15m | 7.76m | 5.00 | -- | -- | -- | -- | -3.82 | -3.82 | 0.00 | -2.65 | 0.00 | -- | -- | 0.00 | -1,266.54 | -493.15 | -- | -- | -- | -- | -- | -10,223.96 | 0.0189 | -1.20 | -- | -- | -- | -- | -41.51 | -- | -- | -- |
| Neurometrix Inc | 5.90m | -6.53m | 8.82m | 26.00 | -- | 0.337 | -- | 1.49 | -6.29 | -6.29 | 5.67 | 13.18 | 0.2561 | 1.23 | 10.13 | 226,977.70 | -28.33 | -23.24 | -29.85 | -27.26 | 66.89 | 59.17 | -110.64 | -48.88 | 15.55 | -- | 0.00 | -- | -28.52 | -18.18 | -47.84 | -- | 5.03 | -- |
| Nexalin Technology Inc | 110.75k | -4.65m | 10.71m | 6.00 | -- | 3.34 | -- | 96.69 | -0.6303 | -0.6303 | 0.015 | 0.4312 | 0.02 | 0.1653 | 15.54 | 18,458.33 | -84.03 | -- | -106.99 | -- | 76.81 | -- | -4,197.48 | -- | 7.70 | -- | 0.00 | -- | -91.62 | -- | -173.80 | -- | -- | -- |
| Biomerica Inc | 5.41m | -6.35m | 11.19m | 62.00 | -- | 1.43 | -- | 2.07 | -0.3789 | -0.3789 | 0.3224 | 0.4642 | 0.5827 | 2.28 | 5.74 | 87,180.80 | -68.45 | -43.55 | -83.73 | -50.32 | 11.41 | 15.75 | -117.46 | -55.86 | 3.37 | -- | 0.00 | -- | -71.71 | -0.8229 | -57.58 | -- | -9.76 | -- |
| Biotricity Inc | 11.63m | -15.39m | 11.92m | 55.00 | -- | -- | -- | 1.02 | -1.75 | -1.75 | 1.32 | -2.84 | 1.92 | 2.01 | 6.55 | 211,408.70 | -240.40 | -303.46 | -- | -- | 65.52 | 53.00 | -125.43 | -368.78 | 0.1012 | -0.5855 | -- | -- | 26.00 | -- | 35.36 | -- | -- | -- |
| ALR Technologies Inc | 9.49k | -8.00m | 12.00m | 6.00 | -- | -- | -- | 1,264.57 | -0.0147 | -0.0147 | 0.00002 | -0.0476 | 0.0358 | -- | -- | 1,581.67 | -3,015.28 | -12,861.64 | -- | -- | 62.49 | -- | -84,283.24 | -406,011.30 | -- | -0.8626 | -- | -- | -- | -- | -42.72 | -- | -- | -- |
| Citrine Global Corp | 0.00 | -2.38m | 12.07m | 18.00 | -- | -- | -- | -- | -0.0025 | -0.0025 | 0.00 | -0.0028 | 0.00 | -- | -- | 0.00 | -173.12 | -298.98 | -- | -964.26 | -- | -- | -- | -4,814.84 | -- | -5.41 | -- | -- | -- | -- | 41.43 | -- | -5.44 | -- |
| Bionoid Pharma Inc | 0.00 | 1.35m | 13.50m | 13.00 | 0.2204 | -- | 9.98 | -- | 1.13 | 1.13 | 0.00 | -0.1744 | -- | -- | -- | -- | -- | -506.64 | -- | -- | -- | -- | -- | -- | -- | 327.24 | -- | -- | -- | -- | -31.55 | -- | 26.01 | -- |
| PetVivo Holdings Inc | 1.05m | -10.63m | 13.75m | 25.00 | -- | 13.66 | -- | 13.14 | -0.8694 | -0.8694 | 0.0842 | 0.06 | 0.3375 | 1.21 | 2.04 | 41,841.60 | -343.12 | -209.90 | -715.73 | -504.64 | 51.41 | 20.27 | -1,016.55 | -2,297.21 | 0.6169 | -2,268.84 | 0.1392 | -- | 693.46 | 260.32 | -73.83 | -- | 51.73 | -- |
| BioSig Technologies Inc | 18.00k | -29.05m | 15.34m | 4.00 | -- | -- | -- | 852.31 | -4.08 | -4.08 | 0.0025 | -0.3222 | 0.0061 | 0.00 | 1.09 | 4,500.00 | -971.23 | -269.73 | -- | -363.11 | 72.22 | -- | -159,388.90 | -24,485.73 | 0.1152 | -- | -- | -- | -93.71 | -- | -6.52 | -- | -9.58 | -- |
| REMSleep Holdings Inc | 203.73k | -1.78m | 15.35m | 6.00 | -- | 16.62 | -- | 75.33 | -0.0012 | -0.0012 | 0.0001 | 0.0006 | 0.0892 | 1.66 | 19.66 | -- | -77.85 | -152.40 | -92.09 | -317.98 | -371.44 | -- | -872.65 | -2,317.52 | 3.18 | -353.98 | 0.00 | -- | -36.48 | -- | 12.13 | -- | 28.26 | -- |
| PAVmed Inc | 2.45m | -66.27m | 15.78m | 107.00 | -- | -- | -- | 6.43 | -9.24 | -9.24 | 0.3392 | -6.28 | 0.0563 | -- | 62.87 | 22,915.89 | -182.01 | -154.56 | -- | -1,152.82 | -161.87 | -- | -3,232.63 | -8,764.89 | 0.447 | -10.58 | 2.19 | -- | 550.40 | -- | 25.76 | -- | 55.51 | -- |
Data as of Apr 26 2024. Currency figures normalised to Biomerica Inc's reporting currency: US Dollar USD
20.45%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Granahan Investment Management, LLCas of 31 Dec 2023 | 1.08m | 6.44% |
| Wasatch Advisors, Inc.as of 31 Mar 2024 | 953.26k | 5.67% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 609.37k | 3.62% |
| Russell Investment Management LLCas of 31 Dec 2023 | 201.56k | 1.20% |
| Potomac Capital Management, Inc.as of 31 Dec 2023 | 167.70k | 1.00% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 149.71k | 0.89% |
| Geode Capital Management LLCas of 31 Dec 2023 | 120.78k | 0.72% |
| CapFinancial Partners LLCas of 31 Dec 2023 | 58.67k | 0.35% |
| G1 Execution Services LLCas of 31 Dec 2023 | 53.83k | 0.32% |
| Perritt Capital Management, Inc.as of 31 Dec 2023 | 42.50k | 0.25% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
